Hong Anh De Sa, MD, is board certified in internal medicine and pediatrics, with fellowship training in hematology and oncology. She is a Northside Hospital Blood and Marrow Transplant, Leukemia, and Immunotherapy Program physician.

Training

• B.A., Neurobiology, Secondary in Global Health and Public Policy, Harvard University, Cambridge, MA

• M.D., Drexel University College of Medicine, Philadelphia, PA

• Residency, Combined Internal Medicine and Pediatrics, Case Western Reserve University/University Hospitals/Rainbow Babies and Children’s Hospital, Cleveland, OH

• Fellowship, Hematology and Oncology, Oregon Health & Science University, Portland, OR

Society Memberships

• American Society for Transplantation and Cellular Therapy

• American Society of Hematology

• American Society of Clinical Oncology

Past Awards

• Clinical Research in Training Institute, American Society of Hematology (2025)

• Research Training Award for Fellows (RTAF), American Society of Hematology (2024)

• 7th Cancer Clinical Trial Methods Workshop at Knight Cancer Institute, Oregon Health & Science University, Portland, OR (2024)

Past Academic Faculty Appointments

• Chief Fellow, Hematology and Oncology, Oregon Health & Science University, Portland, OR (2024-2025)

Publications

• Authored and co-authored multiple research articles and abstracts in peer-reviewed journals: Journal of Pediatric Hematology Oncology, Research and Practice in Thrombosis and Haemostasis, Leukemia & Lymphoma, Cancer Research, and Journal of Clinical Oncology.

Dr. De Sa’s clinical and research interests include blood and marrow transplantation, CAR T-cell therapy, TIL therapy, and acute leukemia and hematologic malignancy therapies.